Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Sayegh

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Urology|February 10, 2022
Editorial CommentNicolas Sayegh, Umang Swami
JCO Precision Oncology|March 21, 2025
Histone Deacetylase Inhibitors in the Management of Advanced CancersNicolas Sayegh, Valerie Etzrodt
The Lancet. Healthy Longevity|October 23, 2022
Benign prostatic hyperplasia: a global challenge of the ageing populationNicolas Sayegh, Kelli Gross
JCO Oncology Practice|September 2, 2021
Recent Advances in the Management of Metastatic Prostate CancerNicolas Sayegh, Umang Swami, Neeraj Agarwal
European Urology Oncology|June 21, 2021
Drug Development for Prostate Cancer with Biochemical Recurrence: Trials and TribulationsNicolas Sayegh, Neeraj Agarwal, Umang Swami
JACC. Cardiooncology|July 12, 2022
Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma TherapiesAvirup Guha, Nicolas Sayegh, Neeraj Agarwal
European Urology|December 13, 2021
Development of Novel Regimens Combining Immune Checkpoint Inhibitors and Radiation Therapy in Prostate CancerUmang Swami, Nicolas Sayegh, Neeraj Agarwal
Cancer Cell|April 16, 2021
Seeing the forest for the trees-single-cell atlases link CD8<sup>+</sup> T cells and macrophages to disease progression and treatment response in kidney cancerMei Yee Koh, Nicolas Sayegh, Neeraj Agarwal
Cancer Treatment and Research Communications|January 31, 2021
Body composition and metastatic prostate cancer survivorshipAdriana M Coletta, Nicolas Sayegh, Neeraj Agarwal
Oncotargets and Therapy|October 3, 2022
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial CarcinomaNicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Urology|February 10, 2022
Editorial CommentNicolas Sayegh, Umang Swami
JCO Precision Oncology|March 21, 2025
Histone Deacetylase Inhibitors in the Management of Advanced CancersNicolas Sayegh, Valerie Etzrodt
The Lancet. Healthy Longevity|October 23, 2022
Benign prostatic hyperplasia: a global challenge of the ageing populationNicolas Sayegh, Kelli Gross
JCO Oncology Practice|September 2, 2021
Recent Advances in the Management of Metastatic Prostate CancerNicolas Sayegh, Umang Swami, Neeraj Agarwal
European Urology Oncology|June 21, 2021
Drug Development for Prostate Cancer with Biochemical Recurrence: Trials and TribulationsNicolas Sayegh, Neeraj Agarwal, Umang Swami
JACC. Cardiooncology|July 12, 2022
Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma TherapiesAvirup Guha, Nicolas Sayegh, Neeraj Agarwal
European Urology|December 13, 2021
Development of Novel Regimens Combining Immune Checkpoint Inhibitors and Radiation Therapy in Prostate CancerUmang Swami, Nicolas Sayegh, Neeraj Agarwal
Cancer Cell|April 16, 2021
Seeing the forest for the trees-single-cell atlases link CD8<sup>+</sup> T cells and macrophages to disease progression and treatment response in kidney cancerMei Yee Koh, Nicolas Sayegh, Neeraj Agarwal
Cancer Treatment and Research Communications|January 31, 2021
Body composition and metastatic prostate cancer survivorshipAdriana M Coletta, Nicolas Sayegh, Neeraj Agarwal
Oncotargets and Therapy|October 3, 2022
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial CarcinomaNicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, et al.
Pageof 8